The Biotech CRO Market was valued at USD 68.14 billion in 2023 and is anticipated to reach USD 114.46 billion by 2032, growing at a CAGR of 5.9% over the forecast period of 2024-2032. The increasing complexity of drug development processes, rising R&D investments, and the growing trend of outsourcing clinical trials to contract research organizations (CROs) are driving the robust growth of the b..